Patent details

Basic Information

Publication number:

EP1689404

PCT Application Number:

PCT/GB/2004/050026

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047987177

PCT Publication Number:

WO/2005/049031

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF ET-743 WITH 5-FLUOROURACIL PRO-DRUGS FOR THE TREATMENT OF CANCER

French Title of Invention:

COMBINAISON DU ET-743 AVEC DES PRO-DRUGS DU 5-FLUOROURACILE POUR LE TRAITEMENT DU CANCER

German Title of Invention:

KOMBINATION VON ET-743 MIT 5-FLUOROURACIL PRO-DRUGS ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

15/11/2004

Grant date:

03/09/2008

EP Publication Date:

03/09/2008

PCT Publication Date:

02/06/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/08/2006

EP B1 Publication Date:

03/09/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/11/2015

Expiration date:

15/11/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/11/2004

 

 

Name:

Pharma Mar S.A.U.

Address:

Poligono Industrial La Mina Avda. de los Reyes, 1 Colmenar, 28770 Madrid, Spain (ES)

Agent

Name:

MARKS & CLERK LLP

From:

12/11/2008

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

Name:

RYBAK Mary, Ellen

Address:

United States (US)

Priority

Priority Number:

519690 P

Priority Date:

13/11/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/498;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56